 |
This Is MS Multiple Sclerosis Community: Knowledge & SupportWelcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones. |
| It is currently Wed Jun 19, 2013 2:30 am |
|
All times are UTC - 8 hours [ DST ] |
 
|
Page 1 of 1 |
[ 1 post ] |
|
| Author | Message | |||||
|---|---|---|---|---|---|---|
| scorpion |
|
|||||
Joined: Wed Nov 05, 2008 4:00 pm Posts: 1323 |
|
|||||
| Top |  |
|||||
 |
||||||
|
|
Page 1 of 1 |
[ 1 post ] |
|
All times are UTC - 8 hours [ DST ] |
| Topics | Author | Replies | Views | Last post | |
|---|---|---|---|---|---|
 | OxyPharma Announces Selection of MS Drug | 5 | 1897 | Fri Apr 15, 2005 7:31 pm | |
| Genmab Announces Interim Results of Ofatumumab Phase II Stud | 0 | 1033 | Tue Jul 06, 2010 12:50 pm | |
Who is online |
Users browsing this forum: No registered users |
| You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum |
News 
Site map 
SitemapIndex 
RSS Feed Channel list
Login
Register
FAQ
